Phase I-IV Focus Independent 35,000 sq. ft. research site specializing in Phase 1 trials with in-house volunteer beds and a dedicated treatment/observation area, signaling strong capacity for early to mid-stage clinical studies.

Capacity Advantage Large in-house bed capacity (100 beds plus 12 hospital beds specialized for dialysis) positions OCRC to accommodate higher patient throughput and complex monitoring, a compelling fit for trials with tighter timelines.

Security and Compliance Upgraded security, card key access, and digitally recorded cameras reflect a disciplined operational environment, appealing to sponsors prioritizing data integrity, patient safety, and regulatory readiness.

Tech Ecosystem Utilizes cloud and web technologies (AWS, WordPress, Google APIs) to support study management, patient engagement, and site visibility, offering opportunities to integrate with sponsor data systems and improve trial transparency.

Mid-Market Positioning Revenue in a mid-range tier with a staff size of 51–200 places OCRC between small CROs and large CROs, suggesting opportunities for scalable partnerships, faster onboarding, and collaboration on mid-scale or specialized studies.